Production of pharmaceutically active proteins in sprouted seedlings
US7683238B2 · kind B2 · utility
5Cited by
98References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2002 |
| Grant date | Mar 23, 2010 |
| Priority date | — |
| Expiry date | Nov 5, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/542
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides systems and methods for producing pharmaceutically active proteins in transgenic sprouted seedlings. The transgenic sprouted seedlings of the invention are grown in a contained, regulatable environment, wherein expression of a pharmaceutically active protein is controlled by an exogenously inducible promoter. The transgenic sprouted seedlings may be eaten live or preferably harvested live to preserve the maximal biological activity of the pharmaceutically active protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.